ARCHIVES

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Groups Urge Passage of Health Care Reform Legislation

January 29, 2010

Arizona First To Get Comprehensive Recognition Under New Guidelines; salmon Names Alberts As His Deputy, With Trent Going To Michigan

March 16, 1990

NCI Grant Awards

October 8, 1993

Interview With Departing NCI Director; Advice To His Successor.

July 9, 2010

Former Senator Cotton Named To NCA

April 11, 1975

Nine Saturation Program Planning Contracts Approved

May 9, 1975